JBC Advanced Glycation Endproducts

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M401280200 on March 26, 2004

J. Biol. Chem., Vol. 279, Issue 23, 24387-24393, June 4, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/23/24387    most recent
M401280200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hui, T. Y.
Right arrow Articles by Davis, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hui, T. Y.
Right arrow Articles by Davis, R. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Mice Lacking Thioredoxin-interacting Protein Provide Evidence Linking Cellular Redox State to Appropriate Response to Nutritional Signals*

To Yuen Hui{ddagger}, Sonal S. Sheth§, J. Matthew Diffley{ddagger}, Douglas W. Potter{ddagger}, Aldons J. Lusis§, Alan D. Attie¶, and Roger A. Davis{ddagger}||

From the {ddagger}Mammalian Cell and Molecular Biology Laboratory, Department of Biology, Molecular Biology Institute and Heart Institute, San Diego State University, San Diego, California 92182, §Molecular Biology Institute and Department of Medicine, Microbiology and Human Genetics, University of California, Los Angeles, California 90095, and Department of Biochemistry, University of Wisconsin, Madison, Wisconsin 53706

Thioredoxin-interacting protein (Txnip) is a ubiquitous protein that binds with high affinity to thioredoxin and inhibits its ability to reduce sulfhydryl groups via NADPH oxidation. HcB-19 mice contain a nonsense mutation in Txnip that eliminates its expression. Unlike normal animals, HcB-19 mice have ~3-fold increase in insulin levels when fasted. The C-peptide/insulin ratio is normal, suggesting that the hyperinsulinemia is due to increased insulin secretion. Fasted HcB-19 mice are hypoglycemic, hypertriglyceridemic, and have higher than normal levels of ketone bodies. Ablation of pancreatic {beta}-cells with streptozotocin completely blocks the fasting-induced hypoglycemia/hypertriglyceridemia, suggesting that these abnormalities are due to excess insulin secretion. This is supported by increased hepatic mRNA levels of the insulin-inducible, lipogenic transcription factor sterol-responsive element-binding protein-1c and two of its targets, acetyl-CoA carboxylase and fatty acid synthase. During a prolonged fast, the hyperinsulinemia up-regulates lipogenesis but fails to down-regulate hepatic phosphoenolpyruvate carboxykinase mRNA expression. Hepatic ratios of reduced:oxidized glutathione, established regulators of gluconeogenic/glycolytic/lipogenic enzymes, were elevated 30% in HcB-19 mice, suggesting a loss of Txnip-enhanced sulfhydryl reduction. The altered hepatic enzymatic profiles of HcB-19 mice divert phosphoenolpyruvate to glyceroneogenesis and lipogenesis rather than gluconeogenesis. Our findings implicate Txnip-modulated sulfhydryl redox as a central regulator of insulin secretion in {beta}-cells and regulation of many of the branch-points of gluconeogenesis/glycolysis/lipogenesis.


Received for publication, February 5, 2004 , and in revised form, March 24, 2004.

* This project was supported by National Institutes of Health Grant HL51648 (to R. A. D.) and American Heart Association Scientist Development Award 0330109N (to T. Y. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| To whom correspondence should be addressed: Mammalian Cell and Molecular Biology Laboratory, Life Sciences Bldg. LS307, 5500 Campanile Dr., San Diego State University, San Diego, CA 92182-4614. Tel.: 619-594-7936. Fax: 619-594-7937; E-mail: rdavis{at}sunstroke.sdsu.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
J. A. Corbett
Thioredoxin-Interacting Protein Is Killing My {beta}-cells!
Diabetes, April 1, 2008; 57(4): 797 - 798.
[Full Text] [PDF]


Home page
DiabetesHome page
J. Chen, G. Saxena, I. N. Mungrue, A. J. Lusis, and A. Shalev
Thioredoxin-Interacting Protein: A Critical Link Between Glucose Toxicity and {beta}-Cell Apoptosis
Diabetes, April 1, 2008; 57(4): 938 - 944.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. T. Y. Hui, A. M. Andres, A. K. Miller, N. J. Spann, D. W. Potter, N. M. Post, A. Z. Chen, S. Sachithanantham, D. Y. Jung, J. K. Kim, et al.
Txnip balances metabolic and growth signaling via PTEN disulfide reduction
PNAS, March 11, 2008; 105(10): 3921 - 3926.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. A. Chutkow, P. Patwari, J. Yoshioka, and R. T. Lee
Thioredoxin-interacting Protein (Txnip) Is a Critical Regulator of Hepatic Glucose Production
J. Biol. Chem., January 25, 2008; 283(4): 2397 - 2406.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. A. Davis
Searching for Causality of Knocking Out Txnip: Is Txnip Missing in Action?
Circ. Res., December 7, 2007; 101(12): 1216 - 1218.
[Full Text] [PDF]


Home page
J. Lipid Res.Home page
K. Reue and L. Vergnes
Thematic review series: Systems Biology Approaches to Metabolic and Cardiovascular Disorders. Approaches to lipid metabolism gene identification and characterization in the postgenomic era
J. Lipid Res., September 1, 2006; 47(9): 1891 - 1907.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Patwari, L. J. Higgins, W. A. Chutkow, J. Yoshioka, and R. T. Lee
The Interaction of Thioredoxin with Txnip: EVIDENCE FOR FORMATION OF A MIXED DISULFIDE BY DISULFIDE EXCHANGE
J. Biol. Chem., August 4, 2006; 281(31): 21884 - 21891.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S.-i. Oka, H. Masutani, W. Liu, H. Horita, D. Wang, S. Kizaka-Kondoh, and J. Yodoi
Thioredoxin-Binding Protein-2-Like Inducible Membrane Protein Is a Novel Vitamin D3 and Peroxisome Proliferator-Activated Receptor (PPAR){gamma} Ligand Target Protein that Regulates PPAR{gamma} Signaling
Endocrinology, February 1, 2006; 147(2): 733 - 743.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Kolbe, A. Tiessen, H. Schluepmann, M. Paul, S. Ulrich, and P. Geigenberger
Trehalose 6-phosphate regulates starch synthesis via posttranslational redox activation of ADP-glucose pyrophosphorylase
PNAS, August 2, 2005; 102(31): 11118 - 11123.
[Abstract] [Full Text] [PDF]


Home page
J Exp BotHome page
P. Geigenberger, A. Kolbe, and A. Tiessen
Redox regulation of carbon storage and partitioning in response to light and sugars
J. Exp. Bot., June 1, 2005; 56(416): 1469 - 1479.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. H. Minn, C. Hafele, and A. Shalev
Thioredoxin-Interacting Protein Is Stimulated by Glucose through a Carbohydrate Response Element and Induces {beta}-Cell Apoptosis
Endocrinology, May 1, 2005; 146(5): 2397 - 2405.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
S. C. Tyagi, W. Rodriguez, A. M. Patel, A. M. Roberts, J. C. Falcone, J. C. Passmore, J. T. Fleming, and I. G. Joshua
Hyperhomocysteinemic Diabetic Cardiomyopathy: Oxidative Stress, Remodeling, and Endothelial-Myocyte Uncoupling
Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2005; 10(1): 1 - 10.
[Abstract] [PDF]


Home page
J. Lipid Res.Home page
S. S. Sheth, L. W. Castellani, S. Chari, C. Wagg, C. K. Thipphavong, J. S. Bodnar, P. Tontonoz, A. D. Attie, G. D. Lopaschuk, and A. J. Lusis
Thioredoxin-interacting protein deficiency disrupts the fasting-feeding metabolic transition
J. Lipid Res., January 1, 2005; 46(1): 123 - 134.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. J. MacDonald, L. A. Fahien, L. J. Brown, N. M. Hasan, J. D. Buss, and M. A. Kendrick
Perspective: emerging evidence for signaling roles of mitochondrial anaplerotic products in insulin secretion
Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E1 - E15.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.